Cubist Systematic Strategies, LLC Pfizer Inc Call Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $3.15 Million - $3.62 Million	-121,600 Reduced 16.75%	604,300 $16.8 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $9.3 Million - $12.1 Million	356,100 Added 96.3%	725,900 $20.9 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $693,144 - $810,216	21,600 Added 6.2%	369,800 $12.3 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $6.41 Million - $7.42 Million	-177,500 Reduced 33.76%	348,200 $12.8 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $1.1 Million - $1.43 Million	27,900 Added 5.6%	525,700 $21.4 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $8.78 Million - $11.5 Million	-210,400 Reduced 29.71%	497,800 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.39 Million - $1.7 Million	31,800 Added 4.7%	708,200 $31 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $30.8 Million - $36.5 Million	662,000 Added 4597.22%	676,400 $35.5 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $658,800 - $816,336	14,400 New	14,400 $745,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.